89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,306,327 | +26.9% | 343,674 | +55.7% | 0.00% | 0.0% |
| Q2 2023 | $4,182,625 | +151.0% | 220,719 | +68.6% | 0.00% | +100.0% |
| Q4 2022 | $1,666,064 | +3371.0% | 130,877 | +930.5% | 0.00% | – |
| Q1 2022 | $48,000 | -73.8% | 12,700 | -9.3% | 0.00% | – |
| Q4 2021 | $183,000 | -33.2% | 14,000 | 0.0% | 0.00% | – |
| Q3 2021 | $274,000 | +4.6% | 14,000 | 0.0% | 0.00% | – |
| Q2 2021 | $262,000 | -6.1% | 14,000 | +18.6% | 0.00% | – |
| Q1 2021 | $279,000 | -3.1% | 11,800 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | +12.1% | 11,800 | +18.0% | 0.00% | – |
| Q3 2020 | $257,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |